Effects of thrombin, PAR-1 activating peptide and a PAR-1 antagonist on umbilical artery resistance in vitro
<p>Abstract</p> <p>Background</p> <p>The non-thrombotic effects of thrombin in cardiovascular tissues, as mediated via the protease activated receptors (PARs), and particularly PAR-1, have been the focus of much recent research. The aims of this study were to evaluate t...
Main Authors: | Elliott John T, Friel Anne M, Ravikumar Nandini, O'Sullivan Crochan J, O'Loughlin Aonghus J, Morrison John J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-02-01
|
Series: | Reproductive Biology and Endocrinology |
Online Access: | http://www.rbej.com/content/3/1/8 |
Similar Items
-
Improved synthesis of the PAR-1 thrombine receptor antagonist RWJ-58259
by: Ángel M. Valdivielso, et al.
Published: (2009-01-01) -
Exploring the Phe-Gly Dipeptide-Derived Piperazinone Scaffold in the Search for Antagonists of the Thrombin Receptor PAR1
by: Ángel M. Valdivielso, et al.
Published: (2014-04-01) -
The role of platelet thrombin receptors PAR1 and PAR4 in health and disease
by: Nylander, Martina
Published: (2011) -
Thrombin receptor signalling in platelets: PAR1, but not PAR4, is rapidly desensitized
by: Haglund, Linda
Published: (2009) -
The role of platelet thrombin receptors PAR1 and PAR4 in platelet activation
by: Vretenbrant Öberg, Karin
Published: (2009)